France looks to partnerships and biotech to drive its industry in 2010
This article was originally published in Scrip
2010 will see the pharmaceutical industry in France use partnerships and biotechnology to help make "health a motor for economic growth", says Christian Lajoux, president of Sanofi-Aventis France and Leem, the French pharmaceutical industry association.
You may also be interested in...
Draft guidelines due out for consultation this week in Italy are expected to shed more light on what companies will have to reveal during pricing and reimbursement negotiations.
Germany is for the first time to adopt national guidelines on prescribing biologics and biosimilars in a move towards increasing biosimilar uptake.
EFPIA, the European Federation of Pharmaceutical Industries and Associations, has put forward what it thinks the European regulatory network strategy to 2025 should prioritize.